Cargando…
Lanthionine Ketimine Ethyl Ester Accelerates Remyelination in a Mouse Model of Multiple Sclerosis
Although over 20 disease modifying therapies are approved to treat Multiple Sclerosis (MS), these do not increase remyelination of demyelinated axons or mitigate axon damage. Previous studies showed that lanthionine ketenamine ethyl ester (LKE) reduces clinical signs in the experimental autoimmune e...
Autores principales: | Dupree, Jeffrey L., Paez, Pablo M., Tiwari-Woodruff, Seema K., Denton, Travis T., Hensley, Kenneth, Angeliu, Christina G., Boullerne, Anne I., Kalinin, Sergey, Egge, Sophia, Cheli, Veronica T., Denaroso, Giancarlo, Atkinson, Kelley C., Feri, Micah, Feinstein, Douglas L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272172/ https://www.ncbi.nlm.nih.gov/pubmed/35791633 http://dx.doi.org/10.1177/17590914221112352 |
Ejemplares similares
-
Deletion of voltage-gated calcium channels in astrocytes decreases neuroinflammation and demyelination in a murine model of multiple sclerosis
por: Denaroso, G. E., et al.
Publicado: (2023) -
Emerging Biological Importance of Central Nervous System Lanthionines
por: Hensley, Kenneth, et al.
Publicado: (2010) -
Iron Metabolism in Oligodendrocytes and Astrocytes, Implications for Myelination and Remyelination
por: Cheli, Veronica T., et al.
Publicado: (2020) -
Substrate Control in Stereoselective Lanthionine Biosynthesis
por: Tang, Weixin, et al.
Publicado: (2014) -
Alleviation of extensive visual pathway dysfunction by a remyelinating drug in a chronic mouse model of multiple sclerosis
por: Sekyi, Maria T., et al.
Publicado: (2021)